Fetal nigral grafts have been demonstrated to survive, secrete dopamine, form synaptic connections with host neurons, and reverse behavioral disturbances in experimental models …
• By using stereotaxic surgical techniques, ventral mesencephalic tissues from aborted human fetuses of 8 to 10 weeks' gestational age were implanted unilaterally into the striata …
JH Kordower, JM Rosenstein, TJ Collier… - Journal of …, 1996 - Wiley Online Library
A patient with Parkinson's disease received bilateral fetal human nigral implants from six donors aged 6.5 to 9 weeks post‐conception. Eighteen months following a post‐operative …
CR Freed, RE Breeze, NL Rosenberg… - Archives of …, 1990 - jamanetwork.com
• In an effort to improve the clinical signs of Parkinson's disease, we have implanted mesencephalic dopamine cells from a 7-week human embryo into the caudate and putamen …
The Europäische Akademie is concerned with the study of the consequences of scientific and technological advance both for the individual and for society at large as well as for the …
One therapeutic approach to treating Parkinson's disease is to convert endogenous striatal cells into levo-3, 4-dihydroxyphenylalanine (L-dopa)-producing cells. A defective herpes …
The successful grafting of homotopic tissue (see Table 1 for terminology), ie neuronal tissue, to the brain has recently increased the interest in the brain as an immunologically privileged …
Objective The main goal of dopamine cell replacement therapy in Parkinson disease (PD) is to provide clinical benefit mediated by graft survival with nigrostriatal reinnervation. We …
Stem cells are a versatile source for cell therapy. Their use is particularly significant for the treatment of neurological disorders for which no definitive conventional medical treatment is …